PharmacovigilanceOfficial
Pleasanton drug discovery firm Cyion to pay $528,336 over alleged False Claims Act grant violations
🇺🇸 HHS OIG · Mon 16 Nov 2026
Cyion Technologies has agreed to pay $528,335.74 to resolve allegations it drew down federal grant funds it was not eligible to receive, according to HHS OIG.
Cyion Technologies LLC, a Pleasanton, California company involved in biological research and drug discovery, has agreed to pay $528,335.74 to resolve allegations under the False Claims Act. HHS OIG published the item on 16 November 2026, pointing to an announcement from the US Attorney's Office for the Northern District of California dated 13 November 2026.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.
Article written by VigiEye from the official source (HHS OIG). AI-assisted; check the source before acting.
More Pharmacovigilance
All →
Real4Reg final symposium at Infarmed showcases real-world data studies and free training
🇵🇹 INFARMED · Mon 16 Nov 2026
Baltic paper-free leaflet project to continue after 2026 with Commission's backing
🇪🇪 Ravimiamet · Mon 16 Nov 2026
Medline details repair and replace programme for recalled beds, rails, mattresses and accessories
🇺🇸 FDA MedWatch · Fri 13 Nov 2026
PRAC publishes final EU-language translations of phenobarbital product information in targeted signal procedure
🇪🇺 EMA · PRAC · Fri 13 Nov 2026
EMA page on veterinary signal management details phenobarbital review and updated MAH templates
🇪🇺 EMA · PRAC · Fri 13 Nov 2026
EMA publishes draft veterinary PV guideline listing medically important VeDDRA terms
🇪🇺 EMA · Fri 13 Nov 2026